Etid klinik pou Siròz nan Texas
13 etid pou Siròz ap chèche patisipan nan sit nan Texas.
Vil nan Texas
Tèks ofisyèl etid la (Anglè)
A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
- Texas Clinical Research Institute, LLC, Arlington
- Epic Medical Research - Carrollton, Carrollton
- The Liver Institute at Methodist Dallas, Dallas
- ak 5 plis
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 30, 2026 · NCT07325526National Liver Cancer Screening Trial
- UT Southwestern Medical Center and Parkland Hospital, Dallas
- Baylor College of Medicine, Houston
Ap rekriteFaz 4
Laj 18 a 85 · Tout sèks · Mizajou Sep 25, 2026 · NCT06084234LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
- Texas Clinical Research Institute, LLC, Arlington
- IMA Clinical Research Austin, Austin
- American Research Corporation - Austin, Austin
- ak 35 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT06632444Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis
- Research Site, Austin
- Research Site, Denison
- Research Site, Georgetown
- ak 4 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT07610837Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
- Liver Center of Texas, Dallas
- Methodist Hospital, Richardson
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jul 10, 2026 · NCT05181826Multi-analyte Blood Test Clinical Trial
- South Texas Research Institute, Edinburg
- Texas Gastro Research, El Paso
- Impact Research Institute, Waco
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jul 10, 2026 · NCT05199259High Dose Albumin in Refractory Ascites
- Baylor St' Lukes Medical center, Houston
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jun 30, 2026 · NCT05867602Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosis
- UT Health San Antonio, San Antonio
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jan 6, 2026 · NCT06526104Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
- Baylor College of Medicine (Scott & White), Dallas
- Michael E DeBakey VA Medical Center, Houston
- Baylor St. Luke's Medical Centre, Houston
Ap rekriteEtid obsèvasyon
Laj 18 a 80 · Tout sèks · Mizajou Oct 20, 2025 · NCT04613921Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk
- University of Texas Southwestern Medical Center, Dallas
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2025 · NCT05028829EGCG for Hepatocellular Carcinoma Chemoprevention
- UT Southwestern, Dallas
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 5, 2025 · NCT06015022Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics
- Methodist Health System, Dallas Medical Center, Dallas
- VA North Texas Healthcare System, Dallas
- Texas Liver Institute, San Antonio
Ap rekriteFaz 1
Laj 18 a 75 · Tout sèks · Mizajou Sep 5, 2025 · NCT05490888Evaluation of Non-Invasive Tests for Metabolic Liver Disease
- First Surgical Hospital, Bellaire
- Endeavor Clinical Trials, San Antonio
Ap rekriteEtid obsèvasyon
Laj 18 a 75 · Tout sèks · Mizajou Aug 14, 2025 · NCT07122700Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.